Exploring acceptance of a possible CHIM (Controlled Human Infection Model) for vaccine development

  • Funded by UK Research and Innovation (UKRI)
  • Total publications:0 publications

Grant number: C19-IUC-330

Grant search

Key facts

  • Disease

    COVID-19
  • Funder

    UK Research and Innovation (UKRI)
  • Principal Investigator

    Dr. Wendy Lawrence
  • Research Location

    United Kingdom
  • Lead Research Institution

    MRC Lifecourse Epidemiology Unit at the University of Southampton
  • Research Priority Alignment

    N/A
  • Research Category

    Vaccines research, development and implementation

  • Research Subcategory

    Pre-clinical studies

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Not applicable

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Working with BRC colleagues on a local public consultation to explore acceptance of a possible CHIM (Controlled Human Infection Model) as part of the effort to fast-track to a vaccine for Covid-19. Seven online focus groups were held with 57 young people aged between 20-40 years. The resultant paper was published in BMC Medicine thus informing others who might be interested in running a CHIM as to the views of the population likely to be recruited to such a trial.